Ikarian Capital, LLC Lyra Therapeutics, Inc. Transaction History

Ikarian Capital, LLC

$754 Million
Q1 2024

A detailed history of Ikarian Capital, LLC transactions in Lyra Therapeutics, Inc. stock. As of the latest transaction made, Ikarian Capital, LLC holds 1,056,829 shares of LYRA stock, worth $295,912. This represents 0.87% of its overall portfolio holdings.

Number of Shares

1,056,829

Previous 1,056,829 -0.0%

Holding current value

$295,912

Previous $6.57 Million -0.0%

% of portfolio

0.87%

Previous 0.87%

12 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 15, 2024	SELL	$4.55 - $6.53 $898,875 - $1.29 Million	-197,555 Reduced 15.75%	1,056,829 $6.57 Million
Q3 2023 Nov 14, 2023	BUY	$2.95 - $4.8 $813,486 - $1.32 Million	275,758 Added 28.18%	1,254,384 $4.9 Million
Q2 2023 Aug 14, 2023	BUY	$1.98 - $4.33 $1.26 Million - $2.75 Million	634,941 Added 184.75%	978,626 $4.02 Million
Q3 2022 Nov 14, 2022	SELL	$5.33 - $6.6 $19,470 - $24,109	-3,653 Reduced 1.05%	343,685 $1.72 Million
Q2 2022 Aug 12, 2022	SELL	$4.12 - $7.51 $309,000 - $563,250	-75,000 Reduced 17.76%	347,338 $1.96 Million

Q1 2022 May 13, 2022	BUY	$3.5 - $5.36 $97,307 - $149,018	27,802 Added 7.05%	422,338 $1.7 Million
Q4 2021 Feb 14, 2022	SELL	$4.22 - $9.41 $37,617 - $83,880	-8,914 Reduced 2.21%	394,536 $1.72 Million
Q3 2021 Nov 15, 2021	SELL	$6.06 - $9.43 $1.34 Million - $2.09 Million	-221,234 Reduced 35.42%	403,450 $3.69 Million
Q2 2021 Aug 16, 2021	SELL	$6.91 - $12.59 $1.08 Million - $1.96 Million	-156,044 Reduced 19.99%	624,684 $5.02 Million
Q1 2021 May 17, 2021	SELL	$10.38 - $15.61 $359,521 - $540,667	-34,636 Reduced 4.25%	780,728 $9.05 Million
Q4 2020 Feb 12, 2021	BUY	$9.28 - $13.88 $3.97 Million - $5.93 Million	427,425 Added 110.18%	815,364 $9.3 Million
Q3 2020 Nov 16, 2020	BUY	$10.61 - $13.96 $4.12 Million - $5.42 Million	387,939 New	387,939 $4.34 Million

Others Institutions Holding LYRA

# of Institutions

Shares Held

44.4M

Call Options Held

300K

Put Options Held

1.3K

View Full List

About Lyra Therapeutics, Inc.

Ticker LYRA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 31,826,400
Market Cap $8.91M
Description
Lyra Therapeutics, Inc., a clinical-stage therapeutics company, focuses on the development and commercialization of novel integrated drug and delivery solutions for the localized treatment of patients with ear, nose, and throat diseases. It's XTreo technology platform is designed to deliver medicines directly to the affected tissue for sustained...

More about LYRA

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Ikarian Capital, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Ikarian Capital, LLC with notifications on news.

Account

Ikarian Capital, LLC Lyra Therapeutics, Inc. Transaction History